Abstract The cytotoxicity of oxidized low-density lipoprotein (Ox-LDL) to arterial smooth muscle cells (SMCs) may contribute to atherogenesis by causing cell death in core regions of plaques. The aim of the present study was to identify the components of copper-oxidized LDL responsible for its toxicity to porcine aortic SMCs. Toxicity to SMCs was assessed as the decrease in viable cell counts after 3-day cell incubation. Extracts of LDL were tested for toxicity at concentrations equivalent to that derived from 100 fig LDL protein per milliliter. Lipid extracts of Ox-LDL but not native-LDL were toxic to SMCs. When separated into neutral and polar lipid classes, only the neutral lipids were toxic (89.7±0.7% cell loss). The neutral lipids were fractionated
' 8 Ox-LDL, however, possesses a number of other potentially atherogenic properties, including cytotoxicity to a variety of different cell types, 2 ' 910 the ability to both stimulate and inhibit cytokine expression in various cells, 1112 stimulation of monocyte chemotactic factor production by endothelial cells, and the capacity to potentiate monocyte-endothelial cell adhesion. 10 Toxicity to smooth muscle cells (SMCs) is presumed to be an important atherogenic process, since these cells are lost from deep-to mid-intimal locations during development of the lipid-rich core region in atherosclerotic plaques. 13 The current study focuses on the cyto-toxicity to SMCs exhibited by Ox-LDL. In 1979 two separate studies appeared showing that LDL was toxic to SMCs and endothelial cells in culture. 9 - 14 It was later demonstrated that the toxicity of LDL to skin fibroblasts could be prevented if LDL was isolated in the presence of antioxidants and with limited exposure to oxygen. 2 In a similar study, Morel and coworkers 3 showed that when LDL was incubated with endothelial cells or SMCs it was rendered toxic to fibroblasts. This could be prevented by adding the lipophilic antioxidant butylated hydroxytoluene during incubation of LDL with the endothelial cells and SMCs. With both chemically oxidized LDL and cell-modified LDL, there was a good correlation between the cytotoxicity of the LDL and the extent of lipid peroxidation, as measured by the concentration of thiobarbituric acid-reacting substances in LDL. In addition, these studies also demonstrated that the toxicity of Ox-LDL could be mimicked by a lipid extract of the LDL. 2 * 3 Together, these observations suggest that a product, or products, of lipid peroxidation may be the cytotoxic intermediates in Ox-LDL.
The oxidation of LDL leads to the formation of a complex array of products, several of which could play a role in its cytotoxicity. These potential cytotoxins include lipid hydroperoxides 15 ; lipid aldehydes, including the highly reactive and toxic alkenals 1 ; oxysterols 16 " 18 ; and lysophosphatidylcholine. 19 Although some of these compounds have been proposed as possible cytotoxins in Ox-LDL, no studies have demonstrated which, if any, of these products accumulate in Ox-LDL to levels sufficient to account for the observed cytotoxicity.
The aim of the present study was to identify the products in copper-oxidized LDL that are cytotoxic to cultured porcine aortic SMCs. Preliminary results demonstrated that, as with the earlier studies on cytotoxicity to fibroblasts, lipid extracts of Ox-LDL were found to be toxic to SMCs. To identify the lipophilic toxin(s), lipid extracts derived from Ox-LDL were separated into several fractions by solid-phase extraction techniques, and each of these fractions was tested for toxicity to SMCs. Toxic fractions then were further purified by high-performance liquid chromatography (HPLC). The HPLC extracts were also incubated with SMCs to determine their cytotoxicity and then analyzed by gas chromatography/mass spectrometry (GC/MS) to identify the toxic components.
Methods Materials 7-Ketocholesterol (5-cholesten-3/J-ol-7-one) and 1,6-diphenyl-l,3,5-hexatriene were purchased from Sigma Chemical Co, 7/3-hydroxycholesterol (5-cholestene-3ft70-diol) from Steraloids, Inc, cholesterol 5a,6a-epoxide (5o,6a-epoxycholestan-3£-ol) from Research Plus Steroid Laboratories, and 5a-cholestane and stigmasterol (3/3-hydroxy-24-ethyl-5,22-cholestadiene) from Mann Research Laboratories, Inc. to(Trimethylsilyl)-trifluoroacetamide containing 1% trimethylchlorosilane (Sylon BFT) was purchased from Supelco, Inc, and other solvents were obtained from Curtin Matheson Scientific, Inc. Fetal bovine serum (FBS) was purchased from HyClone Laboratories, Inc and amphotericin, Waymouth's medium, and Dulbecco's modified Eagle's medium (DMEM) from GIBCO.
Isolation and Oxidation of LDL
Plasma LDL was prepared by ultracentrifugation 20 within a density cutoff of 1.020 to 1.063 g/mL. EDTA (0.5 mg/mL) was added to plasma before ultracentrifugation. LDL was dialyzed initially against 0.02 mol/L Tris buffer, pH 7.4, containing EDTA (0.1 mg/mL) with a final dialysis against degassed phosphate-buffered saline containing no EDTA. Oxidation of LDL was accomplished as previously described 115 in the presence of copper(II) sulfate (5 fimolfL) for 24 hours at 37 C C and was concentrated with an Amicon ultrafiltration unit. LDL protein was determined as described by Lowry and coworkers, 21 using bovine serum albumin as a standard.
Lipid Fractionation
Total lipid extracts of native LDL (N-LDL) and Ox-LDL were prepared by the method of Bligh and Dyer. 22 Initial fractionation of the total lipid extract was accomplished with aminopropyl Bond-Elute extraction columns (Varian) and a modification of the method described by Kaluzny and coworkers. 23 The total lipid extract from 10 to 15 mg LDL protein was dissolved in chloroform (1.5 mL) and loaded on an aminopropyl Bond-Elute column that had been prewashed with hexane (5 mL). The neutral lipids were eluted with 5 mL chloroform/ isopropanol (2:1, vol/vol), and the polar lipid fraction was eluted with 2.5 mL methanol. To further fractionate the neutral lipid extract, the initial eluate was evaporated dry, reconstituted in 1 mL hexane, and loaded on a second aminopropyl column. The column was eluted with 2.5 mL of increasingly polar solvent mixtures to give seven neutral lipid fractions, as follows: fraction 1, ethyl ether/dichloromethane/ hexane (1:5:94, vol/vol/vol); fraction 2, 5% ethyl acetate in hexane; fraction 3, 15% ethyl acetate in hexane; fraction 4, 30% ethyl acetate in hexane; fraction 5, 60% ethyl acetate in hexane; fraction 6, 100% ethyl acetate; and fraction 7, chloroform/methanol (2:1, vol/vol).
HPLC purification of the fractions from the aminopropyl columns was accomplished with a Waters HPLC system composed of two model 6000 pumps, a model 660 solvent programmer, and a U6K injector. A Resolve Radial-Pak cartridge (5 fim, 8x100 mm; Waters) was used for the separation with a linear gradient from 1% isopropanol in hexane to 25% isopropanol in hexane over 25 minutes at a flow of 2.0 mL/min. Fractions were collected for studies in SMC toxicity experiments and for analysis by GC/MS.
In some studies the fractions from the aminopropyl columns were reduced with sodium borohydride. Fractions 5 and 6 from Ox-LDL, N-LDL, and buffer were pooled, evaporated to dryness, and redissolved in 0.5 mL methanol. Sodium borohydride (10 mg) was added, and the samples were kept on ice for 20 minutes and then at room temperature for a further 100 minutes. At this time, 20 /J.L glacial acetic acid was added followed by 1 mL water and extracted with 5 mL hexane/ dichloromethane (1:1, vol/vol). The nonreduced samples were subjected to the same conditions except that sodium borohydride was omitted. Samples were evaporated and redissolved with ethanol for cytotoxicity studies with SMCs.
Incubation With SMCs
Pig aortas were obtained from a local slaughterhouse, and SMCs were isolated by outgrowth from explants into a collagen gel. Briefly, 1-to 2-mm 3 pieces of aortic media were placed in T-25 flasks and covered with a collagen gel prepared from rat-tail tendons. 24 After 30 minutes at 37°C, complete DMEM with 10% FBS and 1% penicillin/streptamicin/amphotericin was added. Media were changed two to three times per week, and after approximately 3 weeks, cells were harvested from the gel by incubation with 0.2% collagenase (Cooper Biomedical, Inc) followed by centrifugation. The cell pellet was resuspended in DMEM with 10% FBS and plated. Cells isolated and passaged in this manner have consistently shown the hill-and-valley pattern of growth, myofilaments by electron microscopy, and immunostaining for SMC actin (HHF35). 25 Cells were frozen at the second or third passage. For SMC toxicity experiments, cells in the fourth or fifth passage were seeded into 2.5-cm, six-well Falcon plates, grown in 10% FBS for 48 hours, and then washed and placed in 0.4% FBS overnight before incubation with LDL or lipid extracts of LDL. Cells were less than 80% confluent and not proliferating during cell toxicity experiments, which were carried out in the presence of 0.4% delipidated FBS. Lipid fractions were dissolved in ethanol to give a final concentration of no more than 2% ethanol in incubations. To control for toxicity due to solvent residues and vehicle effects, buffer extracts, which had been subjected to exactly the same extraction and chromatographic steps as LDL, were run as control samples in all cytotoxicity experiments. After incubation for 3 days, the supernatants were decanted, and the adherent cells were removed from the flasks by trypsinization. These cells were then counted by Coulter counter. The cell toxicity caused by LDL, or extracts of LDL, is expressed as percent cell detachment. This represents the number of adherent cells in buffer extract incubations (see above) minus the number of adherent cells in sample incubations (N-LDL, Ox-LDL, or extracts of these), expressed as a percentage of the adherent cells in buffer extract controls. The percent adherent cells in the incubations with aminopropyl column buffer extracts in a typical experiment was 85.2± 17.3% of the adherent cells after incubation with 0.4% delipidated serum only. To confirm that cell detachment corresponds to cell injury and death in this system, the detached cells from incubations with Ox-LDL and oxysterols were centrifuged, washed, and replated in DMEM with 10% FBS. Fewer than 5% of the cells were capable of replating. The lack of viability of the detached cells was also confirmed through other techniques, including trypan blue staining of detached cells, lactate dehydrogenase release into the culture medium, and release of pHJthymidine from prelabeled cells (J. Guyton, MD, E. Selinger, MD, unpublished observations, June 1993). Differences were observed in the ability of the cells that remained attached to the flasks to proliferate. When cells that remained attached to the flasks after 3-day incubation under control conditions were washed and placed in 10% FBS for 4 days, the number of cells increased 254±6%, whereas the cells that remained attached after 3 days' incubation with Ox-LDL (100 /xg/mL) showed no growth under the same conditions (102±43%).
In some experiments the oxysterols 7-ketocholesterol and 7/J-hydroxycholesterol were added to N-LDL before incubation with SMCs. A solution containing 100 jig 7-ketocholesterol and 40 
Lipid Analysis
Thin-layer chromatography (TLC) was used for an initial screening of the fractions from aminopropyl Bond-Elute columns. Prescored silica gel plates (LK6D; Whatman International Ltd) were used with one of two solvent systems: (1) ethyl ether/hexane/acetic acid (20:79:1, vol/vol/vol) or (2) ethyl ether/hexane/acetic acid (50:50:1, vol/vol/vol). Lipids were visualized under long-wave UV after being sprayed with a solution of 0.1% diphenylhexatriene in hexane. 26 Lipid extracts were derivatized with Sylon BFT (20 fiL). Samples either were heated at 60°C for 1 hour or were left at room temperature overnight, evaporated dry, and redissolved in hexane before GC/MS analysis. Quantification of the oxysterols was accomplished with either stigmasterol or cholestane as an internal standard. Calculations were based on total ion peak-area ratios, with reference to known amounts of authentic standards.
GC and GC/MS Analysis
Samples were analyzed on a Hewlett-Packard (HP) model 5970B mass-selective detector interfaced to a model 5890 GC. Samples were injected in the splitless mode at an injector temperature of 230°C. A DB-1 bonded-phase capillary column (30 mx0.25 mm inner diameter, J&W Scientific) was used for the analyses and kept at 100°C for 2 minutes, then heated to 250°C at 20°C per minute, and then heated to 310°C at 5°C per minute. Full-scan spectra were recorded under electron-impact ionization conditions. Data collection was performed with the HP MS ChemStation (HP-UX series). Quantification of cholestane-triol was accomplished by GC with a flame ionization detector. An HP model 5710A GC modified for capillary columns and equipped with an all-glass falling-needle injector (Allen Scientific Glassblowers, Inc) and interfaced to an HP 3395 integrator was used for the analyses. The column (30 mx0.32 mm inner diameter; DB-1, J&W Scientific) was heated from 225°C to 320°C at 4°C per minute.
Results
Ox-LDL was found to be toxic to porcine aortic SMCs when incubated at concentrations above 50 /xg LDL protein per milliliter. The percentage of detached cells was significantly greater in the case of Ox-LDL than when N-LDL was incubated at the same concentration of LDL protein (Fig 1) . Further analysis indicated that the toxic products were present in a total lipid extract of LDL. To enable correlation with the toxicity observed for nonextracted LDL and lipid extracts of LDL, the concentration of extracts used in cell incubations is referred to as that derived from an equivalent quantity of LDL protein, although no protein remains in the lipid extracts. Incubation of the total lipid extract from Ox-LDL, at a concentration equivalent to that derived from 100 iig LDL protein per milliliter, caused 90±l% of the cells to detach from the flasks, whereas at the same concentration, the extract from N-LDL had no effect on cell viability. Further fractionation into neutral and polar lipid extracts indicated that the toxic lipids were present only in the neutral lipid fraction, with no toxicity observed with the polar lipids (Fig 2) .
In studies aimed at identifying the components of Ox-LDL responsible for cell toxicity, the neutral-lipid extracts of Ox-LDL and N-LDL were separated into seven fractions by elution from aminopropyl bondedphase columns with increasingly polar solvent mixtures. The fractions were analyzed by TLC and checked for toxicity to SMCs at concentrations equivalent to 100 /xg LDL protein per milliliter. TLC indicated that the unoxidized cholesteryl esters eluted in fraction 1, unoxidized triglycerides eluted in fraction 2, and free cholesterol eluted in fraction 3, with a small amount also eluting in fraction 4. There were several bands visible on TLC plates in the fractions from Ox-LDL that were not present in the corresponding fraction from N-LDL; however, only fractions exhibiting toxicity to SMCs were subjected to further analysis. As illustrated in Fig 3, only two of these seven fractions (5 and 6) from Ox-LDL demonstrated significant toxicity to SMCs, and none of those from N-LDL were toxic when incubated at the same concentration. Initial TLC analysis of the two toxic fractions indicated they contained compounds more polar than cholesterol, possibly oxidation products of free cholesterol.
To identify the toxic components, fractions 5 and 6 from both Ox-LDL and N-LDL were pooled and subjected to further separation on normal-phase HPLC. A solvent gradient of increasing isopropanol concentration in hexane was used for the analysis, and fractions were collected at 2-minute intervals. TLC analysis indicated all components eluted in the first eight fractions, and these were tested for toxicity in SMC incubations. When incubated with SMCs at a concentration equivalent to that derived from 100 jag LDL protein per milliliter, none of the HPLC fractions from N-LDL were toxic; however, two HPLC fractions from Ox-LDL, eluting between 11 and 13 minutes and that immediately following (13 to 15 minutes), caused substantial cell detachment. The HPLC fractions from both N-LDL and Ox-LDL extracts were analyzed by GC/MS after derivatization to their trimethylsilyl (TMS) derivatives. Cholesterol derivatives were identified in three of the HPLC fractions from Ox-LDL, but no peaks were observed in the total ion chromatograms of the corresponding fractions from N-LDL. The data are outlined in Table 1 . The first of these HPLC fractions, eluting between 9 and 11 minutes, exhibited two peaks in the total ion chromatogram, both having very similar mass spectra. A high-intensity ion at m/z 474 corresponds to the molecular ion of epoxycholesterol TMS ether. The smaller of the two peaks coeluted with and had a mass spectrum identical to the authentic standard of cholesterol 5a,6a-epoxide as the TMS derivative. The larger, earlier-eluting peak presumably corresponds to the 5/3,6/J-epoxide, which is usually formed in larger quantities than the 5a,6a-isomer after auto-oxidation of cholesterol 27 and elutes earlier than the a-isomer on GC. 28 The HPLC fraction that eluted between 11 and 13 minutes was cytotoxic to SMCs and gave a single peak on the total ion chromatogram. This peak was identified as the TMS ether derivative of 7-ketocholesterol, since it coeluted with and had a mass spectrum identical to the authentic standard. The third HPLC fraction found to contain oxysterols eluted between 13 and 15 minutes, and when analyzed as the TMS derivative, exhibited two peaks in the total ion chromatogram. Both peaks gave essentially identical mass spectra, with a small ion at m/z 546 and the base peak at m/z 456. These ions correspond to the molecular ion of hydroxycholesterol as the bis-TMS ether derivative and loss of trimethylsilanol from the molecular ion. The second and larger of the two peaks coeluted with and had a mass spectrum identical to the TMS derivative of 7)3-hydroxycholesterol. The smaller, earlier peak coeluted with an impurity in the 7)3-hydroxy standard and was identified as the 7a-hydroxyisomer.
Previous studies on the toxicity of oxidation products of cholesterol to cultured SMCs indicated that concentrations in excess of 50 fig/mL were required before significant toxicity was observed. 29 We therefore quantified the oxysterols in the HPLC fractions to determine what concentration was present during our cell incubations, ie, when incubated at a concentration correspond- (19) 382 (34) 233 (2) 233 (4) 382 (28) 367 (2) 369 (31) 369 (27) 366 (32) 367 (69) 129 (3) 129 (4) 367 (70) 233 (2) 366 (54) :m/zt 366 (23) 356 (5) 129 (42) 73 (16) 73 (16) 129 (48) 129 (3) 356 ( ing to 100 fig LDL protein per milliliter. Stigmasterol was used as an internal standard for the analysis of 7-ketocholesterol and 7-hydroxycholesterol. For quantitation of the 5,6-epoxides, cholestane was used as an internal standard, since stigmasterol eluted too close to the 5o,6a-isomer on GC. The concentration of each of these oxysterols used in the SMC experiments is shown in Table 2 along with the observed toxicity of these fractions. The concentration at which the oxysterols were incubated with SMCs was below 5 figlmL, and if these products were indeed responsible for the observed toxicity of the HPLC fractions, they are more potent than has been demonstrated in previous studies. We therefore reexamined the toxicity of the three oxidation products of cholesterol identified in this study. As illustrated in Fig 4, authentic standards of both 7-ketocholesterol and 7-hydroxycholesterol exhibited significant toxicity to cultured porcine aortic SMCs at concentrations well below 10 figlmL, 7/3-hydroxycholesterol being the most potent. The 5a,6a-epoxide demonstrated little toxicity at the concentrations tested and was present at low concentration in SMC incubations, thereby explaining why no toxicity was observed with the HPLC fraction containing this oxysterol. The most cytotoxic oxysterols in earlier studies were found to be 25-hydroxycholesterol and cholestane-3/3,50,6^-triol. 29 We analyzed authentic standards of these oxysterols to determine in which chromatographic fraction they eluted and whether they could also contribute to the cytotoxicity of Ox-LDL. Studies with standards indicated that the very polar cholestane-triol would have eluted in fraction 7 from the aminopropyl column, and this fraction demonstrated no toxicity to SMCs (Fig 2) . GC analysis indicated that the cholestane-triol concentration in this fraction was less than 25 ng per 100 fig LDL protein, explaining the lack of cytotoxicity demonstrated by fraction 7. 25-Hydroxycholesterol, if present in Ox-LDL, would have eluted in fraction 5 from the aminopropyl column. Fraction 5 was one of the fractions exhibiting cytotoxicity; however, HPLC analysis of authentic 25-hydroxycholesterol indicated that it eluted earlier than the other oxysterols and, if present in Ox-LDL, would have been present in the 7-to 9-minute HPLC fraction. This HPLC fraction exhibited no toxicity to SMCs, and GC/MS analysis of this fraction failed to detect any cholesterol derivatives.
Oxysterols 7-hydroxycholesterol and 7-ketocholesterol are formed by decomposition of their unstable precursor, 7-hydroperoxycholesterol. Because of their high reactivity, hydroperoxides can be potent cytotoxins and, if present in significant quantities in Ox-LDL, could contribute to its cytotoxicity. If 7-hydroperoxycholesterol is a more potent cytotoxin than its reduction product 7-hydroxycholesterol, then treatment with sodium borohydride would be expected to decrease cytotoxicity if the hydroperoxide were present in significant amounts. We therefore looked at the effect of chemical reduction with sodium borohydride on the cytotoxicity of Ox-LDL extracts. Because the total lipid extracts of LDL were not completely soluble in methanol (the solvent used in sodium borohydride reductions), we studied the effect of reduction on the cytotoxicity of the aminopropyl column extracts (fraction 5 plus fraction 6). As illustrated in Fig 5, sodium borohydride reduction of Ox-LDL extracts appeared to potentiate the toxicity of the extract, while having little effect on N-LDL extracts.
Because 7-ketocholesterol and 7-hydroxycholesterol were found to account for the toxicity of the lipid extract of Ox-LDL, we added these two oxysterols to N-LDL to determine whether this was sufficient to render it toxic. A mixture of 7-ketocholesterol and 7-hydroxycholesterol was added to N-LDL to give a concentration of oxysterols similar to that in Ox-LDL, 5  fig and 2 fig, respectively, per 100 fig LDL protein (Fig 6A) . The oxysterols caused 94.5±0.4% cell detachment when incubated in the absence of LDL (5 /xg/mL 7-ketocholesterol plus 2 fig/mL 7-hydroxycholesterol). SMC cytotoxicity was observed when the concentration of oxysterols added to N-LDL was increased to fourfold that present in Ox-LDL to yield 4x OS-LDL (Fig 6A) . We also found that N-LDL protected against the cytotoxicity of Ox-LDL when both were incubated with SMCs at 100 fig LDL protein per milliliter (Fig 6B) . 
Discussion
We and others have previously characterized some of the chemical changes that occur during copper oxidation of LDL, including extensive loss of polyunsaturated fatty acids, increased thiobarbituric acid-reactive substances, the formation of hydroperoxy and hydroxy derivatives of linoleate and arachidonate, and increased electrophoretic mobility of the lipoprotein.'• 4 ' 15 In the present study we have shown that Cu 2+ -Ox-LDL is toxic to porcine aortic SMCs and that the toxicity could be mimicked by a lipid extract of Ox-LDL. The toxic compounds were isolated from lipid extracts by solidphase extraction and HPLC and were identified as the unesterified oxysterols 7-ketocholesterol and 7-hydroxycholesterol by GC/MS. Although previous studies have shown that oxidized cholesterol products are present in Ox-LDL 16 ' 17 and that the toxicity of oxysterols has been appreciated for some years, 29 this is the first study clearly identifying two oxysterols as the toxic species in Ox-LDL and demonstrating their presence in Ox-LDL at concentrations sufficient to account for its toxicity.
Oxysterols were first demonstrated to be toxic to SMCs by Peng and coworkers, 29 who studied the cytotoxicity of 12 oxysterols to rabbit aortic SMCs in culture. 25-Hydroxycholesterol and cholestane-3/3,5a,6/3-triol were found to be the most toxic of the oxysterols tested. 7-Ketocholesterol and 7-hydroxycholesterol demonstrated only moderate toxicity in these studies, with concentrations less than 50 /xg/mL exhibiting no cytotoxicity. 26 In the present study 7^-hydroxycholesterol demonstrated a threshold for toxicity at between 1 and 2.5 jug/mL and 7-ketocholesterol showed a toxicity threshold at concentrations between 2.5 and 5 iig/mL. The greater susceptibility of SMCs to the toxicity of oxysterols observed in the current study is probably a result of the different incubation conditions used in the two studies, although the species difference also may influence the results. In the current studies, oxysterols were incubated with subconfluent, nonproliferating cells in the presence of 0.4% delipidated FBS. The earlier studies, in which the oxysterols exhibited toxicity only at high concentrations, were carried out with confluent monolayers of SMCs in 10% FBS. The higher serum and lipid concentrations may affect the availability of the oxysterols to the SMCs and could also alter the susceptibility of SMCs to cytotoxins. Cell density and proliferative state have been shown to influence the susceptibility of cultured cells both to the toxicity of oxysterols 31 and to the toxicity of Ox-LDL. 932 Although 25-hydroxycholesterol and cholestane-triol were found to be the most toxic oxysterols in earlier studies, 29 they do not appear to contribute to the cytotoxicity of Ox-LDL in the current study. The extracts from aminopropyl columns and HPLC in which these oxysterols would have eluted were not found to be cytotoxic, and analysis of these fractions indicated that 25-hydroxycholesterol and cholestane-triol were present in Cu 2+ -Ox-LDL in only trace amounts and probably at concentrations below their toxic-dose threshold. In the current study the 5a,6a-epoxide was the least cytotoxic of the oxysterols studied, demonstrating no effect on SMCs at concentrations below 10 [ig/mL. This is in agreement with the studies of Peng and coworkers, 29 who found that cholesterol epoxide demonstrated no cytotoxicity to SMCs at concentrations up to 100 /ig/mL. In contrast, studies on the inhibition of SMC growth as an index of cytotoxicity have shown 5,6-epoxycholesterol to be more potent than 7-ketocholesterol and to cause growth inhibition at concentrations of 5 /zg/mL. 33 Therefore, although 5,6-epoxycholesterol does not contribute to the SMC toxicity of Ox-LDL, as assessed by cell detachment, its presence in Ox-LDL and effect on SMC growth should not be overlooked when considering possible cytotoxic effects of Ox-LDL in vivo.
The two cytotoxic oxysterols 7-ketocholesterol and 7-hydroxycholesterol are formed from their unstable by guest on July 9, 2017 http://atvb.ahajournals.org/ precursor 7-hydroperoxycholesterol, 34 and it has been suggested that this reactive intermediate could be a potent cytotoxin in Ox-LDL. Our results, however, indicate that 7-hydroperoxycholesterol is not present in Ox-LDL extracts at concentrations that cause significant cytotoxicity to SMCs. This conclusion is supported by the observation that sodium borohydride reduction did not attenuate the cytotoxicity of Ox-LDL extracts and, in fact, a slight increase in toxicity was observed with the reduced extracts (Fig 5) . The potentiation of the toxicity of Ox-LDL, caused by sodium borohydride reduction, is probably due to the conversion of 7-ketocholesterol to the more potent cytotoxin 7-hydroxycholesterol. These results suggest that either 7-hydroperoxycholesterol is not present in the toxic Ox-LDL extracts or that the hydroperoxide is no more toxic than its reduction product, 7-hydroxycholesterol. HPLC and GC/MS analyses would support the conclusion that little if any hydroperoxide is present in the cytotoxic extract. 7-Hydroperoxycholesterol decomposes during GC/MS analysis to form both 7-ketocholesterol and 7-hydroxycholesterol derivatives. 35 None of the HPLC fractions was found to contain both of these compounds, indicating the absence of significant amounts of 7-hydroperoxycholesterol. Although 7-hydroperoxycholesterol does not appear to contribute to the cytotoxicity of Cu 2+ -Ox-LDL in the present study, it is quite possible that different oxidation conditions could lead to different results. Studies of cholesterol oxidation in phospholipid membranes have demonstrated that the amount of 7-hydroperoxide present depends on the nature of the oxidizing conditions: a superoxide-generating system forms higher levels of hydroperoxides than does simple auto-oxidation in buffer. 36 It is therefore possible that LDL oxidized under differing conditions could contain varying amounts of the hydroperoxide, and this unstable compound may in some situations contribute to the cytotoxicity of Ox-LDL.
When the cytotoxic oxysterols 7-ketocholesterol and 7-hydroxycholesterol were added to N-LDL at a concentration equivalent to that present in Ox-LDL, the resulting LDL (ie, OS-LDL) exhibited little cytotoxicity. However, the oxysterols, when incubated with SMCs in the absence of LDL, caused 94.5+0.4% cell detachment (Fig 6A) . A fourfold greater concentration of oxysterols added to N-LDL did cause significant cytotoxicity, although still less than that observed with oxysterols in the absence of LDL. These observations suggest either that oxysterols alone are insufficient to account for the toxicity of Ox-LDL or that N-LDL has a protective effect against oxysterol cytotoxicity. The latter explanation seems more likely, because we have demonstrated that N-LDL was able to protect completely against the cytotoxicity of Ox-LDL (Fig 6B) . How N-LDL exerts its protective effect is not clear but may involve its ability to bind oxysterols and thus lower the effective concentration of oxysterols to which SMCs are exposed. Lipoproteins have been shown to inhibit the transfer of oxysterols to red blood cell membranes, 30 and a similar effect on SMCs could explain our current observations. A similar uptake of oxysterols by HDL could explain the reported protective effect of this lipoprotein against the cytotoxicity of Ox-LDL. 9 The observation that the addition of oxysterols to N-LDL did not render the LDL cytotoxic whereas the same concentration of oxysterols in Ox-LDL apparently is cytotoxic suggests that the oxysterols are released more readily from Ox-LDL than N-LDL. This is possibly caused by the severe disruption of the lipophilic environment that occurs during oxidation of LDL. It is also possible that other oxidation products present in Ox-LDL could act synergistically with 7-ketocholesterol and 7-hydroxycholesterol to increase its cytotoxicity. The current study cannot rule out, however, the possibility that N-LDL is exerting a protective effect by providing the cells with some unknown protective factor rather than limiting exposure of the cells to oxysterols.
The identification of cytotoxic concentrations of oxysterols in Cu 2+ -Ox-LDL may have relevance to the pathogenesis of atherosclerosis, although direct correlation to in vivo situations must be made with care. The concentration of unesterified cholesterol oxidation products in the blood is very low, far below cytotoxic levels 37 " 38 ; however, analysis of saponified plasma and lipoprotein extracts suggests that concentrations of oxysterols in cholesteryl esters may be higher than free oxysterols.
39 " 1 In the present study, fraction 3 from aminopropyl columns, which contained oxidized cholesteryl esters, was not cytotoxic to SMCs (Fig 3) . Although circulating concentrations of unesterified oxysterols may never reach cytotoxic levels, the situation in lipid-filled core regions of atherosclerotic plaques may be different. Cells such as macrophages, which are capable of oxidizing LDL, 42 are present in lesions, and indeed there is evidence for the presence of Ox-LDL in atherosclerotic plaques. 5 Oxysterols, including 7-ketocholesterol, have been identified in atherosclerotic material, 43 but quantification of these compounds is still lacking, and access to fresh material, devoid of autooxidation artifacts, is limited. It is quite possible that, in the lipid-filled core regions of atherosclerotic plaques, oxysterols may reach cytotoxic levels; however, the oxysterol profile in plaque lipids may differ from that found in the present study because the conditions vary considerably. Indeed, some of the cholesterol in advanced lesions is present in crystalline form, 44 and it has been demonstrated that, whereas the C7 oxidation products predominate during oxidation of aqueous dispersions of cholesterol, oxidation of solid cholesterol yields 25-hydroxycholesterol as a major product. 45 Cytotoxicity from crystalline 25-hydroxycholesterol and cholestane-triol has been demonstrated in SMC cultures, 18 and these cytotoxins may well be present in lipids of advanced plaques and contribute, together with other oxysterols, to the lack of cells in core regions of atherosclerotic plaques.
The mechanism by which oxysterols exert their cytotoxicity remains unclear, although a number of possibilities have been suggested. Certain oxysterols are potent inhibitors of 3-hydroxy-3-methylglutaryl (HMG) CoA reductase and therefore lead to decreased cholesterol synthesis within cells. 4647 Inhibition of cholesterol synthesis affects cell growth more than viability, and in the presence of exogenous cholesterol, little effect on growth is observed. 33 In general, oxysterols that are cytotoxic also inhibit HMG CoA reductase, but a close correspondence between the two effects has not been demonstrated. 29 Initial studies in our laboratory indicate that the addition of mevalonate to SMC incubations did not prevent the toxicity of Ox-LDL (J. Guyton, MD, B.L. Black, unpublished observations) suggesting inhibition of HMG CoA reductase is not important in this model. Another mechanism that has been proposed to explain the cytotoxicity of oxysterols involves their incorporation into cell membranes, thus leading to compromised barrier function. This has been demonstrated in model membrane systems in which calcium permeability was increased by 25-hydroxycholesterol, 48 and cholestane-triol increased permeability to glucose. 49 It is unclear whether 7-ketocholesterol and 7-hydroxycholesterol affect membrane permeability in the same way as the more polar oxysterols, because in this latter study these two oxysterols reduced liposomal permeability to glucose. The current study does not enable us to determine the mechanism by which oxysterols cause cytotoxicity to SMCs; further studies will be required to address this important issue.
The present study has concentrated on the toxicity of Ox-LDL to SMCs but Ox-LDL is cytotoxic to other cell types also, including endothelial cells and fibroblasts. Although it has been demonstrated in some instances that the toxicity of Ox-LDL to other cell types could be mimicked by a lipid extract of Ox-LDL, it is unclear whether 7-ketocholesterol and 7-hydroxycholesterol are responsible for the toxicity in other cell types. The methods used for the isolation of toxic fractions from LDL lipids described herein are readily applicable to studies with other cell types and may prove useful in identifying other bioactive components in lipid extracts of Ox-LDL.
